ijcs International Journal of Cardiovascular Sciences Int J Cardiovasc Sci 2359-4802 2359-5647 Sociedade Brasileira de Cardiologia 3xx76DnVjjnDsJTNdpvzKXC S2359-56472021005012204 S2359-56472021000600055 ijcs.20200290 10.36660/ijcs.20200290 ORIGINAL ARTICLE Optimal Cutoff of the TG/HDL-c ratio for Cardiovascular Risk in Hypertensive and Diabetic Patients Monitored by Primary Health Care in a city in Minas Gerais 0000-0002-7257-8747 Silva Eunice Ferreira da 1 0000-0001-5331-9734 Cotta Rosângela Minardi Mitre 1 0000-0002-3014-1504 Mendonça Érica Toledo 1 0000-0003-3804-7413 Oliveira Deíse Moura de 1 0000-0001-6586-6591 Cardoso Silvia Almeida 1 0000-0002-2976-881X Colodette Renata Maria 2 0000-0002-6606-4942 Moreira Tiago Ricardo 1 Universidade Federal de Viçosa Viçosa MG Brazil Universidade Federal de Viçosa, Viçosa, MG – Brazil Fundação Oswaldo Cruz Rio de Janeiro RJ Brazil Fundação Oswaldo Cruz, Rio de Janeiro, RJ – Brazil Mailing Address: Eunice Silva Av. Peter Henry Rolfs, s/n. Postal Code: 36570-000, Campus Universitário, Viçosa, MG – Brazil E-mail: eunice.f.silva@ufv.br

Author contributions

Conception and design of the research: Silva EF, Moreira TR. Analysis and interpretation of the data: Silva EF, Moreira TR. Statistical analysis: Moreira TR. Obtaining financing: Cotta RMM. Writing of the manuscript: Silva EF. Critical revision of the manuscript for intellectual content: Mendonça ET, Oliveira DM, Cardoso SA, Colodette RM, Cotta RMM, Moreira TR. Supervision / as the major investigador: Cotta RMM.

Potential Conflict of Interest

No potential conflict of interest relevant to this article was reported.

 20 08 2021 2021 34 5 Supl 1 55 65 18 07 2020 20 02 2021 18 05 2021 This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background

The analysis of the atherogenic potential of the lipid profile for biomarkers, such as the TG/HDL-c ratio, predicts cardiovascular risk better than isolated lipids.

 Objective

To identify the TG/HDL-c cutoff points for multiple risks (hypertension, Diabetes Mellitus, obesity) and to evaluate the association between sociodemographic, clinical, laboratory, anthropometric, and life habit variables and the TG/HDL-c ratio in hypertensive and/or diabetic individuals in the context of Primary Health Care.

 Methods

This was a cross-sectional study with 833 hypertensive and/or diabetic patients, conducted between August 2017 and April 2018. The cutoff point of the TG/HDL-c were obtained by the ROC curve. Cardiovascular risk was discriminated by TG/HDL-c, categorized by the cutoff and evaluated in relation to multiple risks. The magnitude of the association between TG/HDL-c and independent variables was estimated by logistic regression. The significance level of p<0.05 was adopted for all tests.

 Results

The cutoff values of TG/HDL-c (3.26 for men and 2.72 for women) were more sensitive and less specific than those in the literature. Women (OR=1.90 and 95% CI 1.13-3.20) and men (OR=4.58 and 95% CI 1.78-11.76) with multiple risks, and white men, alcohol users, with a history of stroke, had a higher chance of altered GT/HDL-c. Increases in glycosylated hemoglobin, glycemia, and phosphorus in women, and cholesterol, glycemia, and microalbuminuria in men increased the chances of altered TG/HDL-c. Being a former smoker and black reduced the chance of altered TG/HDL-c in women.

 Conclusions

TG/HDL-c proved to be a good indicator for habitual use in Primary Care.

 Hypertension Diabetes Mellitus Primary Health Care Dyslipidemias Biomarkers Research Support Foundation of the State of Minas Gerais CSA-APQ-03510-13 Research Support Foundation of the State of Minas Gerais 14/2013 Sources of Funding: This study was supported by the Research Support Foundation of the State of Minas Gerais (FAPEMIG) for the project "Prevention of diseases and diseases in patients with hypertension in the context of primary health care: chronic kidney disease on the agenda". Case CSA-APQ-03510-13. Notice 14/2013. Introduction

Currently, cardiovascular diseases (CVD) are one of the most important public health problems in the world and one of the main causes of prolonged hospitalization and health expenditures in Brazil.1 , 2 Among CVD, coronary artery disease (CAD) stands out as the leading cause of death in Brazil3 , 4 and worldwide.3

Dyslipidemias are related to the development of atherosclerosis and, consequently, CAD.5 Early detection of individual cardiovascular risk (CVR) is important to prevent CVD,1 , 5 , 6 define therapy6 and reduce complications1 and mortality.5 CVD prevention is a public health priority, especially in high-risk individuals, such as those diagnosed with arterial hypertension (AH) or Diabetes Mellitus (DM). The use of CVR predictors is important in clinical practice,2 , 7 , 8 and the analysis of the atherogenic potential of lipid profile by biomarkers predicts CAD better than the isolated analysis of lipids, as it reflects the interactions between atherogenic and protective lipid fractions.9

CVR indices included the Castelli I Indices (CT/HDL-c ratio) and II (LDL-c/HDL-c ratio),1 and the Framingham score.1 , 6 Among the estimates calculated from routine laboratory parameters, covered by Primary Health Care (PHC), the proportion of triglycerides in relation to HDL cholesterol (TG/HDL-c ratio) is easily obtained from the patient's lipid profile.5 , 7 The TG/HDL-c ratio, proposed by Gaziano et al.10 as a strong lipid predictor for acute myocardial infarction, has been used as an indicator of dyslipidemias8 and cardiometabolic risks (obesity, AH and DM),5 , 7 being a potent predictor of the development of CAD.8 , 9 , 11

The TG/HDL-c ratio dispenses with personnel and specialized techniques,12 it is a safe, economical, fast-to-obtain, practical, and easy-to-use atherogenic marker.2 , 7 For these reasons, its use can be especially considered in PHC.8

Several studies have suggested cutoff points to indicate CVR, whether equal values for Brazilian elderly men and women8 or different values for Japanese adult men and women.5 However, studies whose cutoffs have been calculated specifically for the Brazilian hypertensive and/or diabetic population are unknown. Thus, the present study’s objective is to identify the cutoff of the TG/HDL-c ratio for multiple risks (AH, DM and obesity) and to evaluate sociodemographic, clinical, laboratory, anthropometric, and life habit factors associated with the altered TG/HDL-c ratio in individuals diagnosed with AH and/or DM, in the context of PHC.

 Methods Study design, sample size calculation, and participants

This is a cross-sectional study that is part of a larger project,13 which followed the ethical precepts of Resolution 466/2012 of the National Health Council and was approved by the Ethics Committee of the Federal University of Viçosa (CAAE: 47356115.3.0000.5153). This study’s participants included adult and elderly users of the Brazilian Unified Health System (SUS in Portuguese), in a municipality of Minas Gerais, Brazil. The minimum sample (719) was calculated (Statcalc, Epi-Info®) based on the population of 6,624 hypertensive and/or diabetic patients registered according to the Municipal Health Department. The final sample included 833 individuals over 18 years of age, who were hypertensive and/or diabetic and who received followed up by the Family Health Strategy. Excluded from the data collection were those individuals who did not continue their follow-up visits, as well as pregnant women, abusive users of alcohol and/or drugs, individuals with severe clinical conditions, and those with established chronic kidney disease (CKD).

 Data collection

Data were collected in the Basic Health Units between August 2017 and April 2018. Sociodemographic data, life habits, and health care were collected through semi-structured questionnaires, previously tested in a pilot study, applied by trained researchers. Blood pressure was measured by trained professionals and classified according to the 7th Brazilian Guidelines on Arterial Hypertension (2016).14

The weight, in kilograms (Kg), was obtained on an electronic scale with a capacity of 150 kg and division of 50 grams. Stature, in meters, was measured in a portable anthropometer, with a metal platform for positioning of individuals and dismountable wooden column, with millimeter tape and cursor for reading, according to Jelliffe techniques (1966).15 The body mass index (BMI), calculated by the Weight/Stature2 ratio (Kg/m2), was classified according to World Health Organization (WHO) criteria (2000)16 for adults, and Lipschitz criteria (1994)17 for the elderly. The waist and hip perimeters were measured in centimeters (cm) with inextensible measuring tape. The hip perimeter values were obtained at the level of the maximum extension of the buttocks, with the tape positioned transversely to the measured segment, on the skin, without excessive pressure. Waist perimeter values were obtained at the midpoint between the iliac crest and the external face of the last rib and classified as "increased" in relation to the risk for non-communicable chronic diseases when they presented measurements of ≥94cm for men and of ≥80cm for women, according to the WHO (2000).16 The waist-hip (WHR) and waist-height (WHT) relationships were calculated by dividing the waist perimeter values by hip perimeter and stature, respectively. The reference values for CVR of the WHR for men (≥0.90) and women (≥0.85) were those recommended by the WHO (2000),16 while the WHT (≥0.5) between genders was recommended by Ashwell and Hsieh (2005).18

Biological samples were collected after 12 hours of fasting, and the biological materials were analyzed in an accredited laboratory, using commercial kits and techniques, together with reference criteria. Microalbuminuria (mg/dL) tests were performed, as were tests for serum albumin, phosphorus, calcium, and creatinine (mg/dL); fasting glucose (FG) (mg/dL); glycosylated hemoglobin (HbA1c) (%); triglycerides (TG) (mg/dL); total cholesterol (TC) and fractions - high lipoproteins (HDL-c) and low densities (LDL-c) (mg/dL). The TG/HDL-c ratio (dependent variable) was calculated from plasma lipid dosages, dividing the TG values by cholesterol linked to HDL-c. The results of FG and HbA1c were classified as altered (FG-126mg/dL and HbA1c-6.5%) according to the criteria of the American Diabetes Association, adopted by the Brazilian Diabetes Society (2018).19

The Glomerular Filtration Rate (GFR) (mL/min/1.73m2) was estimated from serum creatinine by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. The criterion for CKD was based on Kidney Disease: Improving global Outcomes (KDIGO 2012),20 considering the values of GFR < 60 mL/min/1.73m2.

 Statistical analysis

Statistical analyses were performed using computer software programs (SPSS version 20). For descriptive analysis and characterization of the population, absolute and relative frequencies of categorical and mean variables, medians, standard deviations, and interquartile intervals of continuous variables were estimated. Pearson's chi-square test was used to verify associations between categorical variables. The statistically important differences between the continuous variables were verified by the unpaired Student t-tests (parametric) or Mann Whitney U (non-parametric) test, according to the normality of the data. The normality of the distribution was tested by the Shapiro-Wilk test. The significance level of p <0.05 was adopted for all tests.

The cutoff of the TG/HDL-c ratio for CVR discrimination in relation to multiple risk factors (AH, DM, and obesity classified by BMI) were obtained by the Receiver Operating Characteristic (ROC) curve. The ideal cutoff points were selected maximizing the Youden index. The discrimination of the TG/HDL-c ratio was measured by the area under the ROC curve (AUC). The 95% confidence interval (CI) for AUC was estimated by the DeLong method (1988). The sensitivity, specificity, and accuracy of the identified cutoff points, and others already described in the literature,5 , 8 were presented.

The magnitude of the association between the TG/HDL-c ratio (categorized by the obtained cutoff points) and the population characteristics were estimated by logistic regression models. The analyses were stratified by sex. Bilateral probability (p) values of less than 0.05 were considered to indicate statistical significance in the multivariate model. To evaluate the magnitude of the associations, the Odds Ratio (OR) and respective 95% CI were used.

 Results

Table 1 shows the characteristics of the subjects by gender. The participants were classified as overweight by BMI and presented WHR and WHT in the increased CVR range. The median values of BMI and WHT in women and WHR in men were higher. CVR-related variables were significantly higher in women, and 27 men and 87 women accumulated the three risk factors.

– Characteristics of hypertensive and/or diabetic patients followed by the Family Health Strategy in Viçosa, Minas Gerais, Brazil, 2017-2018
Variables General (N=833) Men (n=310) Women (n=523) p
Age* (years of age) 62.0(54.0-69.0) 63.0(55.0-69.0) 62.0(53.0-69.0) 0.443
Years of study* 4.0(3.0-7.0) 4.0(3.0-8.0) 4.0(2.0-6.0) 0.062
Formal/informal work with income† (%) 217(26.0) 107(49.3) 110(50.7) 2.000
Marital status with partner† (%) 488(58.6) 216(44.3) 272(55.7) <0.001
Ethnicity/white color† (%) 261(31.3) 106(40.6) 155(59.4) 0.248
Smokers† (%) 91(11.0) 40(44.0) 51(56.0) <0.001
Ex-smokers† (%) 227 (27.2) 136(59.9) 91(40.1)
Alcohol users† (%) 209(25.0) 132(63.2) 77(36.8) <0.001
Hypertension† (%) 769(92.3) 282(36.7) 487(63.3) 0.260
Diabetes† (%) 413(49.5) 163(39.5) 250(60.5) 0.182
Obesity† (%) 234(28.0) 53(22.6) 181(77.4) <0.001
Multiple risk factors†,‡ (%) 114(13.7) 27(23.7) 87(76.3) 0.001
Weight* (Kg) 71,5(63.0-82.0) 75.0(65.7-85.5) 70.0(62.0-81.0) <0.001
Stature* (cm) 158 (152-166) 167(161-171) 155(150-159) <0.001
Body mass index* (Kg/m2) 28.30(25.22-32.05) 27.18(24.31-30.08) 29.21(25.87-33.27) <0.001
Waist perimeter§ (cm) 93.74±11.31 94.28±10.58 93.42±11.72 0.284
Hip perimeter* (cm) 102.0(96.0-109.0) 100.0(95.0-106.0) 103.0(97.0-111.0) <0.001
Waist/height ratio* 0.59 (0.54-0.63) 0.56 (0.53-0.60) 0.60 (0.55-0.66) <0.001
Waist/hip ratio* 0.91(0.85-0.96) 0.94 (0.89-0.98) 0.88 (0.83-0.94) <0.001
Systolic blood pressure* (mmhg) 130.0(120.0-140.0) 130.0(120.0-141.0) 130.0 (120.0-140.0) 0.585
Diastolic blood pressure* (mmhg) 80.0 (80.0-90.0) 80.0(80.0-90.0) 80.0 (76.0-90.0) 0.044
Total cholesterol§ (mg/dl) 191.4±40.7 188.3±41.1 193.3±40.3 0.082
Triglycerides* (mg/dl) 126.0 (95.0-174.0) 118.5 (86.0-170.0) 129.0 (100.0-175.0) 0.019
LDL-c* (mg/dl) 111.53±34.69 110.89±33.75 111.91±35.26 0.681
HDL-c* (mg/dl) 49.0 (41.0-59.0) 45.5 (39.0-55.0) 51.0 (43.0-61.0) <0.001
Ratio TG/HDL-c* 2.57 (1.73-3.95) 2.58 (1.73-4.17) 2.50 (1.73-3.85) 0.546
Glucose* (mg/dl) 98.0 (88.0-126.0) 101.0 (88.0-129.0) 97.0 (87.0-125.0) 0.188
Glycosylated hemoglobin* (%) 6.0 (5.6-7.0) 6.0 (5.6-7.1) 6.0 (5.6-6.9) 0.915
Use of medicines* (number) 2.0 (1.0-4.0) 2.0 (1.0-4.0) 3.0 (1.0-4.0) 0.001
Use of hypoglycemic agents† (%) 269 (32.30) 102 (37.9) 167(62.1) 0.772
Use of lipid-lowering† (%) 236 (28.33) 76(32.2) 160(67.8) 0.060
Creatinine* (mg/dl) 0.85(0.71-0.99) 0.98(0.86-1.13) 0.77(0.68-0.88) <0.001
Albumin* (mg/dl) 4.47(4.30-4.64) 4.56(4.39-4.74) 4.42(4.26-4.59) <0.001
Phosphorus* (mg/dl) 3.40 (3.00-3.80) 3.20(2.90-3.60) 3.50(3.20-3.90) <0.001
Calcium* (mg/dl) 9.50(9.20-9.70) 9.50(9.30-9.80) 9.50 (9.20-9.70) 0.258
Glomerular filtration rate* (ml/min/1,73m2) 83.0(71.0-97.0) 82.0(69.0-96.0) 84.5(72.0-100.0) 0.080
Microalbuminuria* (mg/dl) 5.0(3.0-11.0) 5.0(3.0-11.0) 5.0(3.0-11.0) 0.636

Values expressed in absolute numbers (percentages), means ± standard deviations, medians (percentiles 25-75). *Mann Whitney U test. †Pearson’s Chi-square test. ‡Presentation of hypertension, diabetes and obesity. §Student’s t-test.

Figure 1 shows the results of the ROC analysis for the relationships between TG/HDL-c and RCV factors. The optimal cutoff values of the TG/HDL-c ratio for multiple risks were 3.26 for men and 2.72 for women (p<0.001), lower than the reference ratio (=3.5) for both genders,8 as well as for women (=3.75)5 and for men (=3.0).5 The new values showed greater accuracy and sensitivity, and lower specificity than conventional ones ( Table 2 ).

– Receptor operation characteristic (ROC) curves for TG/HDL-c ratio and multiple risk factors for males and females.

– Sensitivity and specificity for relationships of multiple risk factors with the TG/HDL-c ratio defined by conventional and new cutoff values for both genders
Conventional cut-off value8: Male and Female = 3.5 Conventional cutoff values5: Male = 3.0 and Female = 3.75 Suggested cutoff values: Male = 3.26 and Female = 2.72
Female
Sensitivity 42.53% 56.32% 63.22%
Specificity 72.48% 64.45% 58.26%
Accuracy 0.575 0.604 0.620
Male
Sensitivity 66.67% 51.85% 70.37%
Specificity 68.55% 72.08% 65.02%
Accuracy 0.676 0.620 0.698

Considering the cutoff points established by the ROC curve, the TG/HDL-c ratio was categorized as adequate (<3.26 for men, <2.72 for women) and changed (≥3.26 for men, ≥2.72 for women). Men with altered TG/HDL-c ratio were observed as more obese; more frequently of multiple risks; higher median values of weight, BMI, hip perimeter, WHT, and WHR; higher waist perimeter averages; higher mean levels of TG, FG, HbA1c, creatinine, and albumin; and lower HDL-c. A higher proportion of men with adequate TG/HDL-c used hypoglycemic agents ( Table 3 ). Women with an altered TG/HDL-c ratio were observed as more obese, with a higher frequency of multiple risks; median values of weight, BMI, hip perimeter, WHT, and WHR; higher waist perimeter averages; higher median levels of TG and FG; and lower HDL-c when compared to those with an adequate TG/HDL-c ratio. A higher proportion of women with an altered TG/HDL-c ratio were diabetic, used hypoglycemic agents and were active smokers, while a higher proportion of former smokers and nonsmokers showed an adequate TG/HDL-c ( Table 3 ).

– Sociodemographic characteristics; lifestyle; and clinical, biochemical, and anthropometric parameters according to the TG/HDL-c ratio by gender
Variables (N=833) Ratio TG/HDL-c male p Ratio TG/HDL-c female p
Adequate < 3.26 Changed ≥ 3.26 Adequate < 2.72 Changed ≥ 2.72
Gender (%) 191(61.6) 119(38.4) 285(54.5) 238(45.5)
Age* (years of age) 63.0(54.0-71.0) 63.0(55.0-69.0) 0.556 61.0(53,.0-69.0) 62.5(54.0-69.0) 0.347
Years of study* 4.0(2.0-7.0) 4.0(3.0-8.0) 0.194 4.0(2.0-6.0) 4.0(3.0-6.0) 0.446
Marital Status† (%) 0.662 0.164
Single 22(71.0) 9(29.0) 35(64.8) 19(35.2)
Married/friendly 132(61.1) 84(38.9) 147(54.0) 125(46.0)
Separated/divorced 18(66.7) 9(33.3) 22(44.0) 28(56.0)
Widowers 9(56.2) 7(43.8) 68(58.1) 49(41.9)
Ethnicity/color† (%) 0.064 0.003
Black 43(74.1) 15(25.9) 81(68.6) 37(31.4)
Brown/yellow/indigenous 77(63.1) 45(36.9) 108(50.2) 107(49.8)
White 59(55.7) 47(44.3) 80(51.6) 75(48.4)
Employment situation† (%) 0.952 0.740
Workers with income 64(59.8) 43(40.2) 61(55.5) 49(44.5)
Housewife 3(60.0) 2(40.0) 78(54.2) 66(45.8)
Retired 106(63.1) 62(36.9) 129(55.6) 103(44.4)
Unemployed 18(60.0) 12(40.0) 17(45.9) 20(54.1)
Smoking† (%) 0.945 0.024
Smokers 24(60.0) 16(40.0) 22(43.1) 29(56.9)
Former smokers 85(62.5) 51(37.5) 60(65.9) 31(34.1)
Never smoked 68(63.0) 40(37.0) 184(54.0) 157(46.0)
Alcohol users† (%) 76(57.6) 56(42.4) 0.122 47(61.0) 30(39.0) 0.235
Hypertensive† (%) 174(61.7) 108(38.3) 0.918 263(54.0) 224(46.0) 0.409
Diabetics† (%) 97(59.5) 66(40.5) 0.423 122(48.8) 128(51.2) 0.012
Obese† (%) 24(45.3) 29(54.7) 0.007 83(45.9) 98(54.1) 0.004
Multiple risk factors†, ‡ (%) 8(29.6) 19(70.4) <0.001 32(36.8) 55(63.2) <0.001
Use of medicines (number of) 2.0(1.0-4.0) 2.0(1.0-3.0) 0.793 3.0(1.0-4.0) 3.0(2.0-5.0) 0.080
Use of hypoglycemic agents† (%) 72(70.6) 30(29.4) 0.023 79(47.3) 88(52.7) 0.024
Use of lipid-lowering† (%) 46(60.5) 30(39.5) 0.823 83(51.9) 77(48.1) 0.425
Weight* (Kg) 72.0(63.5-82.0) 79.5(70.0-89.0) <0.001 67.0(59.1-78.5) 72.0(63.0-82.0) <0.001
Stature* (cm) 167(160-171) 168(163-172) 0.092 154(149-158) 155(150-160) 0.056
Continuation
Body mass index* (Kg/m2) 26.49(23.45-29.27) 28.17(25.34-31.18) <0.001 28.39(25.29-32.32) 30.64(26.91-33.73) 0.001
Waist perimeter§ (cm) 92.19±10.34 97.63±10.13 <0.001 90.95±10.97 96.31±11.93 <0.001
Hip perimeter* (cm) 99.5(93.0-104.5) 101.5(96.0-106.0) 0.040 102.0(96.0-110.5) 104.0(97.5-112.0) 0.035
Waist/height ratio* 0.56(0.52-0.59) 0.59(0.55-0.62) <0.001 0.59(0.54-0.64) 0.62(0.56-0.67) <0.001
Waist/hip ratio* 0.92(0.88-0.96) 0.96(0.92-1.00) <0.001 0.87(0.82-0.93) 0.90(0.85-0.96) <0.001
Systolic blood pressure* (mmHg) 130.0(120.0-140.0) 130.0(120,.0-145.0) 0.691 130.0(120.0-140.0) 130.0(120.0-140.0) 0.484
Diastolic blood pressure* (mmHg) 80.0(80.0-90.0) 80.0(80.0-90.0) 0.903 80.0(77.0-88.0) 80.0(74.0-90.0) 0.608
Total cholesterol§ (mg/dL) 182.87±37.44 196.92±45.24 0.005 190.47±36.95 196.76±43.84 0.080
Triglycerides* (mg/dL) 95.0(77.0-115.0) 195.0(153.0-262.0) <0.001 102.0(85.0-121.0) 178.0(150.0-223.0) <0.001
LDL-c* (mg/dL) 107.0(83.8-133.0) 112.2(86.2-138.5) 0.647 105.8(88.6-131.0) 107,8(88.6-136.6) 0.469
HDL-c* (mg/dL) 51.0(44.0-61.0) 39.0(34.0-44.0) <0.001 59.0(52.0-67.0) 43.0 (38.0-48.0) <0.001
Glucose (mg/dL) 96.0(87.0-126.0) 108.0(94.0-135.0) 0.001 95.0(86.0-119.0) 101.0(89.0-134.0) 0.005
Glycosylated hemoglobin* (%) 5.9(5.5-7.1) 6.1(5.7-7.3) 0.040 5.9(5.6-6.9) 6.1(5.7-7.0) 0.052
Creatinine* (mg/dL) 0.96(0.84-1.10) 1.00(0.89-1.18) 0.037 0.77(0.68-0.87) 0.77(0.68-0.89) 0.477
Albumin* (mg/dL) 4.54(4.37-4.71) 4.61(4.46-4.78) 0.035 4.40(4.26-4.57) 4.45(4.28-4.61) 0.119
Phosphorus* (mg/dL) 3.20(2.90-3.60) 3.20(2.80-3.50) 0.666 3.50(3.10-3.80) 3.60(3.20-3.90) 0.057
Calcium* (mg/dL) 9.50(9.30-9.70) 9.50(9.30-9.80) 0.442 9.50(9.20-9.70) 9.50(9.30-9.80) 0.003
Glomerular filtration rate* (mL/min/1,73m2) 84.0(72.0-97.0) 79.0(67.0-92.0) 0.085 85.0(73.0-101.0) 83.0(71.0-99.0) 0.319
Microalbuminuria* (mg/dL) 5.0(3.0-10.0) 6.0(3.0-15.0) 0.076 5.0(3.0-10.0) 6.0(4.0-13.0) 0.061

Values expressed in absolute numbers (percentages), averages ± standard deviations, medians (percentiles 25-75). *Mann Whitney U test. †Pearson's chi-square test. ‡Presentation of hypertension, diabetes, and obesity. §Student t-test.

The reasons for chance (95% CI) for the variables that remained in the final multivariate model were presented by gender ( Table 4 ). Men with multiple risks were 4.58 times more likely to have an altered TG/HDL-c ratio than those without multiple risks, and frequent users of alcoholic beverages were 3.29 times more likely to have an altered TG/HDL-c ratio than non-users. Participants with a previous history of stroke had a 2.90 times higher chance of altered TG/HDL-c ratio than those without this history. A correlation was found between the altered TG/HDL-c ratio and increased TC, FG, and microalbuminuria. White individuals showed a chance of having an altered TG/HDL-c ratio that was 2.40-fold higher than individuals of black ethnicity/color. For women with multiple risks, the chance of altered TG/HDL-c increased by 90%. Smoking cessation (former smokers) represented a protective factor, decreasing the chance of altered TG/HDL-c by 2.86-fold when compared to active smokers. The chance of altered TG/HDL-c increased by 33% for each 1% increase in HbA1c, by 1% in each 1 mg/dL increase of FG, and by 61% in each 1 mg/dL increase of phosphorus. Self-declared brown/yellow/indigenous and white women were twice as likely to have altered TG/HDL-c than black women ( Table 4 ).

– Probability of TG/HDL-c ratio changed for gender by adjusted multivariate analysis for each individual component of the participants.
Analyzed variable Male Female
OR (95% CI) OR (95% CI)
Multiple Risks (Yes) 4.58(1.78-11.76) 1.90(1.13-3.20)
Glucose (mg/dL) 1.006(1.000-1.011) 1.013(1.005-1.021)
Ethnicity (Black) 1 1
Ethnicity (Brown/Yellow/Indigenous) 1.61(0.75-3.46) 2.15(1.31-3.54)
Ethnicity (White) 2.40(1.10-5.22) 2.04(1.20-3.47)
Alcohol Use (Yes) 3.29 (1.13-9.58) NA
Stroke (Yes) 2.90(1.06-7.92) NA
Total Cholesterol (mg/dL) 1.01(1.00-1.02) NA
Microalbuminuria (mg/dL) 1.002(1.000-1.005) NA
Smoking (Smoker) NA 1
Smoking (Former Smoker) NA 0.35(0.16-0.74)
Smoking (Never Smoked) NA 0.54(0.28-1.02)
Glycosylated Hemoglobin (%) NA 1.33(1.04-1.70)
Serum Phosphorus (mg/dL) NA 1.61(1.10-2.35)

NA = Not applicable

Discussion

In the present study, the cutoff points for the TG/HDL-c ratio of 3.26 for men and 2.72 for women, adults, and the elderly, hypertensive and/or diabetic, users of PHC were identified. These results are lower than those used in Brazil in both male and female elderly individuals,8 those found for Japanese adults,5 and much lower than conventional cutoff values of 3.75 in men and of 3.00 in women calculated using each of the cutoff values for triglycerides (150 mg/dL in men and women) and HDL cholesterol (40 mg/dL in men and 50 mg/dL in women).

High plasma level of LDL-c and TG, and low levels of HDL-c, are important factors of CVR.3 , 21 Lipid reasons can be used for early detection of individual CVR.5 The LDL-c/HDL-c ratio is a classic index for predicting AD, but the TG/HDL-c ratio is the best predictor for acute myocardial infarction, associated with insulin resistance and metabolic syndrome.5 The TG/HDL-c ratio correlates directly with plasma LDL-c levels, type B,5 , 8 reported as an independent CVR factor.5 To identify cardiac and metabolic threats, it is important to use different TG/HDL-c ratio cutoff points between genders,5 , 11 as the HDL-c level is higher in women.5 Different cutoff values for men and women are, in fact, used in the National Cholesterol Education Program's (NCEP) criteria for metabolic syndrome.22 Therefore, it is reasonable that there is also a gender difference in the cutoff of the TG/HDL-c ratio: the values were higher in men than in women ( Figure 1 ). Thus, it is preferable to use different cutoff values of the TG/HDL-c ratio for men and women.

It was evidenced that the altered TG/HDL-c ratio, identified from the cutoff points found in this study, was associated with the presence of multiple risks (AH, DM, and obesity), ethnicity, alcohol use, smoking, history of stroke; CT, FG and HbA1c dosages; and high microalbuminuria and high serum phosphorus. Other studies have identified associations between the TG/HDL-c ratio and several cardiometabolic risk factors, such as alcohol use,7 smoking,8 metabolic syndrome,23 , 24 oxidative25 and inflammatory profiles,12 , 25 adverse events,10 , 26 various anthropometric parameters,5 , 8 , 9 , 24 , 27 dyslipidemias,12 , 24 , 27 HA.5 , 8 , 11 DM,5 , 8 , 11 , 24 , 28 insulin resistance,11 , 23 , 28 , 29 and renal function.30 In this sense, the cutoff points found represent the CVR well and are therefore good risk markers for the studied population.

The cutoff values of the TG/HDL-c ratio can be obtained through quartiles;10 tertiles;11 for convenience, from values already used by other researchers;8 , 9 , 26 , 28 , 30 or even calculated through the ROC curve.5 Gaziano et al. (1997)10 calculated the relative risks per quartiles, comparing the TG/HDL-c ratio levels of the second, third, and fourth quartiles with those of the first quartile. Ain et al. (2019)11 divided the TG/HDL-c ratio into three tercis (0.1-3.59; 3.60-7.18; and 7.19-10.3). Some authors agreed on different TG/HDL-c ratio cutoff values for the sexes (2.5 for women and 3.5 for men,9 or 3.00 for women and 3.75 for men5 ), while others pre-established the values regardless of gender (2.526 ; 3.028 , 29 ; 3.58 and 3.830 ), or they calculated them by ROC analysis (2.967 for men and 2.237 for women)5 .

The importance of identifying cutoff values by ROC analysis is due to obtaining more satisfactory values for this population (hypertensive and diabetic), which presents more CVR factors, in the instance where it is attended (PHC). The cutoff for the TG/HDL-c ratio depends on its associated result, and a result that produces greater accuracy in ROC analysis is preferable to determine the cutoff value of the TG/HDL-c ratio. However, because they are obtained for a specific population, the suggested cutoff cannot be extrapolated to the population in general. However, in a study of cardiometabolic risk factors (AH, DM, and visceral obesity) in periodic health examination records of 10,196 Japanese adults, it was concluded that the power of discrimination of cardiometabolic risk factors of the TG/HDL-c ratio, using conventional cutoff values and obtained by ROC analysis, were similar when applying both methods.5 The values suggested in the studies mentioned above or presented in the study by Wakabayashi and Daimon (2019)5 may not fit this population, as they were conducted in other countries and/or with populations with CVRs that were different from those to which hypertensive and/or diabetic patients are subject, or because they were not calculated, but obtained for convenience in the literature. In the present study, the accuracy values for the TG/HDL-c ratio in relation to multiple risks (AH, DM, and obesity) were 0.698 in men and 0.620 in women ( Figure 1 ), which are generally evaluated as low precision (AUC: 0.5 ~ 0.7) but were higher than the accuracy presented by conventional cutoff values ( Figure 1 ). Recent prospective studies conducted in Iran31 and China32 showed similar accuracy (0.575 and 0.647).

Considering that the components (TG and HDL-c) are simple, and are already found in routine laboratory tests,23 the TG/HDL-c ratio can be easily obtained from the patient's lipid profile.5 , 7 - 9 The use of CVR predictors is relevant in clinical practice,9 and the use of the TG/HDL-c ratio as one of these indices can avoid the indiscriminate use of laboratory tests and related expenses.23 In addition, the TG/HDL-c ratio has specific characteristics, such as simplicity, low cost, applicability,27 ease of execution,5 reliability, practicality, speed in obtaining results, and non-invasive test qualities,8 making it a useful indicator to predict CVR in routine and screening tests,5 especially in the context of primary health care.8

 Strengths and limitations of the study

The present study presents as strengths the achievement of the cutoff values of the TG/HDL-c ratio by ROC analysis with a more satisfactory and effective result to discriminate CVR; having been conducted with adults and the elderly – a population with a tendency to present more CVR-factors, and at the level of PHC – aninstance in which hypertensive and diabetic patients are treated. Limitations of the study include a cross-sectional design, which is insufficient to express a causal association between the TG/HDL-c ratio and the studied variables; the difficulty of comparison with other studies due to the methodological differences of obtaining results and the cutoff values of TG/HDL-c; as well as the non-analysis of food intake and physical activity data. It is suggested that longitudinal, multicenter, and/or prospective additional studies should be conducted to discuss the causative relationships and temporal correlations of CVRs with the TG/HDL-c ratio.

 Conclusion

For a population of hypertensive and/or diabetic patients, cutoff values for the TG/HDL-c ratio (3.26 for males and 2.72 for females) were lower than those commonly used in clinical practice. These values showed greater accuracy and sensitivity and less specificity than conventional values. It was also observed that the new cutoff points indicative of altered TG/HDL-c were associated with the presence of multiple risks (AH, DM, and Obesity), ethnicity, alcohol use, smoking, history of stroke, and increased values of TC, FG, HbA1c, microalbuminuria, and serum phosphorus.

These results suggest the use of new cutoff points in the clinical practice of follow-up of patients with AH and DM in PHC, aiming to achieve early screening and the appropriate treatment of risk factors that may indicate an undesirable prognosis in this population.

 Acknowledgment

The authors express gratitude to the researchers of the Laboratory of Studies in Health Planning and Management (LabPlanGest) and the Innovation Program in University Teaching (PRODUS) of the Federal University of Viçosa who participated in the collection and tabulation of data.

 References 1. Soares LP, Fabbro ALD, Silva AS, Sartorelli DS, Franco LF, Kuhn PC, et al. Cardiovascular Risk in Xavante Indigenous Population. Arq Bras Cardiol. 2018;110(6):542-50. doi: 10.5935/abc.20180090. Soares LP Fabbro ALD Silva AS Sartorelli DS Franco LF Kuhn PC et al Cardiovascular Risk in Xavante Indigenous Population Arq Bras Cardiol 2018 110 6 542 550 10.5935/abc.20180090. 2. Silva ARA, Dourado KF, Pereira PB, Lima DSC, Fernandes AO, Andrade AM, et al. Razão TG/HDL-c e Indicadores Antropométricos Preditores de Risco para Doença Cardiovascular. Rev Bras Cardiol. 2012;25(1):41–9. Silva ARA Dourado KF Pereira PB Lima DSC Fernandes AO Andrade AM et al Razão TG/HDL-c e Indicadores Antropométricos Preditores de Risco para Doença Cardiovascular Rev Bras Cardiol 2012 25 1 41 49 3. Garcez MR, Pereira JL, Fontanelli MM, Marchioni DM, Fisberg RM. Prevalence of Dyslipidemia According to the Nutritional Status in a Representative Sample of São Paulo. Arq Bras Cardiol. 2014;103(6):476-84. doi: 10.5935/abc.20140156. Garcez MR Pereira JL Fontanelli MM Marchioni DM Fisberg RM Prevalence of Dyslipidemia According to the Nutritional Status in a Representative Sample of São Paulo Arq Bras Cardiol 2014 103 6 476 484 10.5935/abc.20140156. 4. Sicchieri LB. Caracterização da Lipoproteína de Baixa Densidade (LDL) por Meios Espectroscópicos [dissertation]. São Paulo: Universidade de São Paulo; 2012. Sicchieri LB Caracterização da Lipoproteína de Baixa Densidade (LDL) por Meios Espectroscópicos dissertation São Paulo Universidade de São Paulo 2012 5. Wakabayashi I, Daimon T. Comparison of Discrimination for Cardio-Metabolic Risk by Different Cut-Off Values of the Ratio of Triglycerides to HDL Cholesterol. Lipids Health Dis. 2019;18(1):156. doi: 10.1186/s12944-019-1098-0. Wakabayashi I Daimon T Comparison of Discrimination for Cardio-Metabolic Risk by Different Cut-Off Values of the Ratio of Triglycerides to HDL Cholesterol Lipids Health Dis 2019 18 1 156 10.1186/s12944-019-1098-0. 6. Précoma DB, Oliveira GMM, Simão AF, Dutra OP, Coelho OR, Izar MCO, et al. Atualização da Diretriz de Prevenção Cardiovascular da Sociedade Brasileira de Cardiologia – 2019. Arq Bras Cardiol. 2019; 113(4):787-891. doi: 10.5935/abc.20190204. Précoma DB Oliveira GMM Simão AF Dutra OP Coelho OR Izar MCO et al Atualização da Diretriz de Prevenção Cardiovascular da Sociedade Brasileira de Cardiologia – 2019 Arq Bras Cardiol 2019 113 4 787 891 10.5935/abc.20190204. 7. Andrade MIS, Dourado KF, Lima CR, Orange LG, Bento RA, Rodrigues DAS, et al. Razão Triglicerídeo/HDL-C como Indicador de Risco Cardiovascular em Alcoolistas Crônicos. Rev Bras Cardiol. 2012;25(4):267–75. Andrade MIS Dourado KF Lima CR Orange LG Bento RA Rodrigues DAS et al Razão Triglicerídeo/HDL-C como Indicador de Risco Cardiovascular em Alcoolistas Crônicos Rev Bras Cardiol 2012 25 4 267 275 8. Martins MV, Souza JD De, Martinho KO, Franco FS, Tinôco ALA. Associação entre razão Triglicerídeos e HDL-colesterol e fatores de risco cardiovascular em idosos atendidos na estratégia saúde da família de Viçosa, MG. Rev Bras Geriatr e Gerontol. 2017;20(2):236–43. doi: 10.1590/1981-22562017020.160059. Martins MV Souza JD De Martinho KO Franco FS Tinôco ALA Associação entre razão Triglicerídeos e HDL-colesterol e fatores de risco cardiovascular em idosos atendidos na estratégia saúde da família de Viçosa, MG Rev Bras Geriatr e Gerontol 2017 20 2 236 243 10.1590/1981-22562017020.160059. 9. Almeida AF, Sena MHLG, Gomes TS, Ramos LB, Gobatto ALN, Conceição MEP, et al. Razão TG/HDL-c, Indicadores Antropométricos e Bioquímicos de Risco Cardiovascular no Renal Crônico em Tratamento Conservador. Nutr Clin y Diet Hosp. 2017;37(4):10–6. doi: 10.12873/374fortes. Almeida AF Sena MHLG Gomes TS Ramos LB Gobatto ALN Conceição MEP et al Razão TG/HDL-c, Indicadores Antropométricos e Bioquímicos de Risco Cardiovascular no Renal Crônico em Tratamento Conservador Nutr Clin y Diet Hosp 2017 37 4 10 16 10.12873/374fortes. 10. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction. Circulation. 1997;96(8):2520-5. doi: 10.1161/01.cir.96.8.2520. Gaziano JM Hennekens CH O'Donnell CJ Breslow JL Buring JE Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction Circulation 1997 96 8 2520 2525 10.1161/01.cir.96.8.2520. 11. Ain QU, Asif N, Alam A, Gilani M, Shahzad N, Sheikh W. Triglycerides-to-HDLC Ratio as a Marker of Cardiac Disease and Vascular Risk Factors in Adults. J Coll Physicians Surg Pak. 2019;29(11):1034-7. doi: 10.29271/jcpsp.2019.11.1034. Ain QU Asif N Alam A Gilani M Shahzad N Sheikh W Triglycerides-to-HDLC Ratio as a Marker of Cardiac Disease and Vascular Risk Factors in Adults J Coll Physicians Surg Pak 2019 29 11 1034 1037 10.29271/jcpsp.2019.11.1034. 12. Vieira EA, Carvalho WA, Aras Júnior R, Couto FD, Couto RD. Razão Triglicérides/HDL-C e proteína C Reativa de Alta Sensibilidade na Avaliação do Risco Cardiovascular. J. Bras. Patol. Med. Lab. 2011;47(2):113–8. doi: 10.1590/S1676-24442011000200004. Vieira EA Carvalho WA Aras R Júnior Couto FD Couto RD Razão Triglicérides/HDL-C e proteína C Reativa de Alta Sensibilidade na Avaliação do Risco Cardiovascular J. Bras. Patol. Med. Lab 2011 47 2 113 118 10.1590/S1676-24442011000200004. 13. Comini LO, Oliveira LC, Borges LD, Dias HH, Batistelli CRS, Silva LS, et al. Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care. Diabetes Metab Syndr Obes. 2020;13:71-80. doi: 10.2147/DMSO.S223929. Comini LO Oliveira LC Borges LD Dias HH Batistelli CRS Silva LS et al Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care Diabetes Metab Syndr Obes 2020 13 71 80 10.2147/DMSO.S223929. 14. Malachias MVB, Souza WKSB, Plavnik FL, Rodrigues CIS, Brandão AA, Neves MFT, et al. 7 Diretriz Brasileira de Hipertensão Arterial. Arq Bras Cardiol. 2016;107(3Supl.3):1–83. doi: 10.5935/abc.20160152. Malachias MVB Souza WKSB Plavnik FL Rodrigues CIS Brandão AA Neves MFT et al 7 Diretriz Brasileira de Hipertensão Arterial Arq Bras Cardiol 2016 107 3Supl 3 1 83 10.5935/abc.20160152. 15. Jelliffe DB. World Health Organization. The assessment of the nutritional status of the community [Internet]. Geneva: World Health Organization; 1966 (cited 2021 Jul 07). Available from: https://apps.who.int/iris/handle/10665/41780 Jelliffe DB World Health Organization The assessment of the nutritional status of the community Internet Geneva World Health Organization 1966 cited 2021 Jul 07 https://apps.who.int/iris/handle/10665/41780 16. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva: WHO Tech Rep Ser; 2000. World Health Organization Obesity: Preventing and Managing the Global Epidemic Geneva WHO Tech Rep Ser 2000 17. Lipschitz DA. Screening for Nutritional Status in the Elderly. Prim Care. 1994;21(1):55-67. Lipschitz DA Screening for Nutritional Status in the Elderly Prim Care 1994 21 1 55 67 18. Ashwell M, Hsieh SD. Six Reasons Why the Waist-to-Height Ratio is a Rapid and Effective Global Indicator for Health Risks of Obesity and How its Use could Simplify the International Public Health Message on Obesity. Int J Food Sci Nutr. 2005;56(5):303-7. doi: 10.1080/09637480500195066. Ashwell M Hsieh SD Six Reasons Why the Waist-to-Height Ratio is a Rapid and Effective Global Indicator for Health Risks of Obesity and How its Use could Simplify the International Public Health Message on Obesity Int J Food Sci Nutr 2005 56 5 303 307 10.1080/09637480500195066. 19. Oliveira JEP, Montenegro RM Jr, Vencio S, Foss-Freitas MC. Diretrizes da Sociedade Brasileira de Diabetes 2017-2018. São Paulo: Clannad; 2018. Oliveira JEP Montenegro RM Jr Vencio S Foss-Freitas MC Diretrizes da Sociedade Brasileira de Diabetes 2017-2018 São Paulo Clannad 2018 20. Kirsztajn GM, Filho NS, Draibe SA, Netto MV, Thomé FS, Souza E, Bastos MG. Fast reading of the KDIGO 2012: guidelines for evaluation and management of chronic kidney disease in clinical practice. J Bras Nefrol. 2014;36(1):63-73. doi: 10.5935/0101-2800.20140012. Kirsztajn GM Filho NS Draibe SA Netto MV Thomé FS Souza E Bastos MG Fast reading of the KDIGO 2012: guidelines for evaluation and management of chronic kidney disease in clinical practice J Bras Nefrol 2014 36 1 63 73 10.5935/0101-2800.20140012. 21. Silva RC, Diniz MF, Alvim S, Vidigal PG, Fedeli LM, Barreto SM. Physical Activity and Lipid Profile in the ELSA- Brasil Study. Arq Bras Cardiol. 2016;107(1):10-9. doi: 10.5935/abc.20160091. Silva RC Diniz MF Alvim S Vidigal PG Fedeli LM Barreto SM Physical Activity and Lipid Profile in the ELSA- Brasil Study Arq Bras Cardiol 2016 107 1 10 19 10.5935/abc.20160091. 22. Nakazone MA, Pinheiro A, Braile MC, Pinhel MA, Sousa GF, Pinheiro S Jr, et al. Prevalence of metabolic syndrome using NCEP-ATPIII and IDF definitions in Brazilian individuals. Rev Assoc Med Bras. 2007;53(5):407-13. doi: 10.1590/s0104-42302007000500016. Nakazone MA Pinheiro A Braile MC Pinhel MA Sousa GF Pinheiro S Jr et al Prevalence of metabolic syndrome using NCEP-ATPIII and IDF definitions in Brazilian individuals Rev Assoc Med Bras 2007 53 5 407 413 10.1590/s0104-42302007000500016. 23. Baez-Duarte BG, Zamora-Gínez I, González-Duarte R, Torres-Rasgado E, Ruiz-Vivanco G, Pérez-Fuentes R, Celis TMRGOD. Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Index as a Reference Criterion of Risk for Metabolic Syndrome (MetS) and Low Insulin Sensitivity in Apparently Healthy Subjects. Gac Med Mex. 2017;153(2):152-8. Baez-Duarte BG Zamora-Gínez I González-Duarte R Torres-Rasgado E Ruiz-Vivanco G Pérez-Fuentes R Celis TMRGOD Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Index as a Reference Criterion of Risk for Metabolic Syndrome (MetS) and Low Insulin Sensitivity in Apparently Healthy Subjects Gac Med Mex 2017 153 2 152 158 24. Girona J, Amigó N, Ibarretxe D, Plana N, Rodríguez-Borjabad C, Heras M, et al. HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk. Int J Mol Sci. 2019;20(13):3151. doi: 10.3390/ijms20133151. Girona J Amigó N Ibarretxe D Plana N Rodríguez-Borjabad C Heras M et al HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk Int J Mol Sci 2019 20 13 3151 10.3390/ijms20133151. 25. Baez-Duarte BG, Ríos-Fuentes JC, Zamora-Ginez I, Mendoza-Carrera F, Briones-Rojas R. Relationship of Triglycerides/High Density Lipoprotein-Cholesterol Index With Antioxidant Defense And Outstanding Association With High Sensitive C-Reactive Protein In Mexican Subjects. Int J Public Heal Clin Sci. 2018;5(2):169–79. Baez-Duarte BG Ríos-Fuentes JC Zamora-Ginez I Mendoza-Carrera F Briones-Rojas R Relationship of Triglycerides/High Density Lipoprotein-Cholesterol Index With Antioxidant Defense And Outstanding Association With High Sensitive C-Reactive Protein In Mexican Subjects Int J Public Heal Clin Sci 2018 5 2 169 179 26. Sultani R, Tong DC, Peverelle M, Lee YS, Baradi A, Wilson AM. Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients. Heart Lung Circ. 2020;29(3):414-21. doi: 10.1016/j.hlc.2019.03.019. Sultani R Tong DC Peverelle M Lee YS Baradi A Wilson AM Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients Heart Lung Circ 2020 29 3 414 421 10.1016/j.hlc.2019.03.019. 27. Miralles CSW, Wollinger LM, Marin D, Genro JP, Contini V, Dal Bosco SM. Waist-to-Height Ratio (WHtR) and Triglyceride to HDL-C ratio (TG/HDL-c) as Predictors of Cardiometabolic Risk. Nutr Hosp. 2015;31(5):2115-21. doi: 10.3305/nh.2015.31.5.7773. Miralles CSW Wollinger LM Marin D Genro JP Contini V Dal Bosco SM Waist-to-Height Ratio (WHtR) and Triglyceride to HDL-C ratio (TG/HDL-c) as Predictors of Cardiometabolic Risk Nutr Hosp 2015 31 5 2115 2121 10.3305/nh.2015.31.5.7773. 28. Borrayo G, Basurto L, González-Escudero E, Diaz A, Vázquez A, Sánchez L, et al. TG/HDL-C Ratio as Cardio-Metabolic Biomarker Even in Normal Weight Women. Acta Endocrinol. 2018;14(2):261-7. doi: 10.4183/aeb.2018.261. Borrayo G Basurto L González-Escudero E Diaz A Vázquez A Sánchez L et al TG/HDL-C Ratio as Cardio-Metabolic Biomarker Even in Normal Weight Women Acta Endocrinol 2018 14 2 261 267 10.4183/aeb.2018.261. 29. Pantoja-Torres B, Toro-Huamanchumo CJ, Urrunaga-Pastor D, Guarnizo-Poma M, Lazaro-Alcantara H, Paico-Palacios S, et al. High Triglycerides to HDL-Cholesterol Ratio is Associated with Insulin Resistance in Normal-Weight Healthy Adults. Diabetes Metab Syndr. 2019;13(1):382-8. doi: 10.1016/j.dsx.2018.10.006. Pantoja-Torres B Toro-Huamanchumo CJ Urrunaga-Pastor D Guarnizo-Poma M Lazaro-Alcantara H Paico-Palacios S et al High Triglycerides to HDL-Cholesterol Ratio is Associated with Insulin Resistance in Normal-Weight Healthy Adults Diabetes Metab Syndr 2019 13 1 382 388 10.1016/j.dsx.2018.10.006. 30. Moraes LL, Santos ALG dos, Dias LPP, Oliveira D de A, Mafra D, Martins ICV da S. Identificação de Risco Cardiovascular pela Razão Triglicerídeo/HDL-Colesterol em Pacientes com Doença Renal Crônica em Hemodiálise. Sci Med. 2017;27(3):7. doi:10.15448/1980-6108.2017.3.27369. Moraes LL Santos ALG dos Dias LPP Oliveira D de A Mafra D Martins ICV da S Identificação de Risco Cardiovascular pela Razão Triglicerídeo/HDL-Colesterol em Pacientes com Doença Renal Crônica em Hemodiálise Sci Med 2017 27 3 7 10.15448/1980-6108.2017.3.27369. 31. Gharipour M, Sadeghi M, Dianatkhah M, Nezafati P, Talaie M, Oveisgharan S, et al. Comparison between European and Iranian Cutoff Points of Triglyceride/High-Density Lipoprotein Cholesterol Concentrations in Predicting Cardiovascular Disease Outcomes. J Clin Lipidol. 2016;10(1):143-9. doi: 10.1016/j.jacl.2015.10.008. Gharipour M Sadeghi M Dianatkhah M Nezafati P Talaie M Oveisgharan S et al Comparison between European and Iranian Cutoff Points of Triglyceride/High-Density Lipoprotein Cholesterol Concentrations in Predicting Cardiovascular Disease Outcomes J Clin Lipidol 2016 10 1 143 149 10.1016/j.jacl.2015.10.008. 32. Deng QW, Li S, Wang H, Lei L, Zhang HQ, Gu ZT, et al. The Short-Term Prognostic Value of the Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio in Acute Ischemic Stroke. Aging Dis. 2018;9(3):498-506. doi: 10.14336/AD.2017.0629. Deng QW Li S Wang H Lei L Zhang HQ Gu ZT et al The Short-Term Prognostic Value of the Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio in Acute Ischemic Stroke Aging Dis 2018 9 3 498 506 10.14336/AD.2017.0629.

Sources of Funding: T his study was supported by the Research Support Foundation of the State of Minas Gerais (FAPEMIG) for the project "Prevention of diseases and diseases in patients with hypertension in the context of primary health care: chronic kidney disease on the agenda". Case CSA-APQ-03510-13. Notice 14/2013.